重症CRGNB相关肺炎静脉使用黏菌素时负荷剂量的必要性:多中心观察性研究
该多中心回顾性研究纳入ICU收治的CRGNB相关院内肺炎并接受静脉黏菌素治疗的患者,分为负荷剂量组(N=85)与非负荷剂量组(N=127),倾向性评分匹配后每组N=67进行比较。负荷剂量组第14天临床有效比例(55.2% vs 35.8%,p=0.037)和微生物清除率(50% vs 27.3%,p=0.042)高于非负荷剂量组,住院时间更短(52 vs 60,p=0.037),Kaplan-Meier分析显示生存时间更长;第7、14、28天死亡率及总住院死亡率两组无差异,急性肾损伤风险无显著差异。作者据此推荐重症CRGNB院内肺炎静脉用黏菌素时给予负荷剂量。
要点
- 倾向性评分匹配后(每组N=67),负荷剂量组第14天临床有效比例55.2% vs 非负荷组35.8%(p=0.037)。
- 负荷剂量组第14天微生物清除率50% vs 非负荷组27.3%(p=0.042)。
- 负荷剂量组住院时间短于非负荷组(52 vs 60,p=0.037),Kaplan-Meier分析显示生存时间更长。
- 第7、14、28天死亡率及总住院死亡率两组无差异,急性肾损伤风险无显著差异。
- 作者推荐重症CRGNB院内肺炎静脉用黏菌素时给予负荷剂量。
适用人群与场景
- ICU收治的、由碳青霉烯耐药革兰阴性菌(CRGNB)所致院内肺炎并接受静脉黏菌素治疗的患者。
处置流程与药物剂量
- 作者推荐:重症CRGNB所致院内肺炎静脉使用黏菌素时给予负荷剂量。
研究设计与关键结果
- 多中心回顾性研究,纳入ICU收治的CRGNB相关院内肺炎并接受静脉黏菌素治疗的患者,负荷剂量组N=85、非负荷剂量组N=127,倾向性评分匹配重要协变量后每组N=67进行比较。
- 负荷剂量组第14天临床有效比例高于非负荷剂量组(55.2% vs 35.8%,p=0.037)。
- 负荷剂量组第14天微生物清除率高于非负荷剂量组(50% vs 27.3%,p=0.042)。
- 第7、14、28天死亡率及总住院死亡率两组无差异,但Kaplan-Meier分析显示负荷剂量组生存时间长于非负荷剂量组。
- 负荷剂量组住院时间短于非负荷剂量组(52 vs 60,p=0.037)。
- 两组急性肾损伤发生风险无显著差异。
证据类型、等级与局限
- 证据类型:多中心回顾性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者推荐对ICU收治的CRGNB所致院内肺炎患者静脉使用黏菌素时给予负荷剂量,依据为负荷剂量组第14天临床有效比例和微生物清除率更高、住院时间更短,且急性肾损伤风险无显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The importance or necessity of a loading dose when prescribing intravenous colistin has not been well established in clinical practice, and approximate one-third to half of patients with carbapenem-resistant gram-negative bacteria (CRGNB) infection did not receive the administration of a loading dose. The aim of this study is to investigate the efficacy and risk of acute kidney injury when prescribing intravenous colistin for critically ill patients with nosocomial pneumonia caused by CRGNB.
METHODS: This was a multicenter, retrospective study that recruited ICU-admitted patients who had CRGNB-associated nosocomial pneumonia and were treated with intravenous colistin. Then, we classified the patients into colistin loading dose (N = 85) and nonloading dose groups (N = 127). After propensity-score matching for important covariates, we compared the mortality rate, clinical outcome and microbiological eradication rates between the groups (N = 67).
RESULTS: The loading group had higher percentages of patients with favorable clinical outcomes (55.2% and 35.8%, p = 0.037) and microbiological eradication rates (50% and 27.3%, p = 0.042) at day 14 than the nonloading group. The mortality rates at days 7, 14 and 28 and overall in-hospital mortality were not different between the two groups, but the Kaplan-Meier analysis showed that the loading group had a longer survival time than the nonloading group. Furthermore, the loading group had a shorter length of hospital stay than the nonloading group (52 and 60, p = 0.037). Regarding nephrotoxicity, there was no significant difference in the risk of developing acute kidney injury between the groups.
CONCLUSIONS: The administration of a loading dose is recommended when prescribing intravenous colistin for critically ill patients with nosocomial pneumonia caused by CRGNB.
参考来源
- Wang SH, Yang KY, Sheu CC, et al. The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study. Crit Care. 2022. PMID: 35379303. doi:10.1186/s13054-022-03947-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。